Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Fish and Richardson
US Army

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for Patent: 9,309,229

« Back to Dashboard

Which drugs does patent 9,309,229 protect, and when does it expire?

Patent 9,309,229 protects ZYKADIA and is included in one NDA.

This patent has thirty-five patent family members in twenty-three countries.

Summary for Patent: 9,309,229

Title:Crystalline forms of 5-chloro-N2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-N4-[2-(propan- e-2-sulfonyl)-phenyl]-pyrimidine-2, 4-diamine
Abstract: The present invention describes specific crystalline forms of 5-chloro-N-(2-isopropoxy-5-methyl-4-(piperidin-4-ylphenyl)-N-2-(isopropyl- sulfonyl)phenyl)-2,4-diamine. The present invention further relates to methods for preparing said crystalline forms, pharmaceutical compositions comprising said crystalline forms, and methods of using said crystalline forms and pharmaceutical compositions to treat disease.
Inventor(s): Feng; Lili (Pine Brook, NJ), Gong; Baoqing (Morris Plains, NJ), Karpinski; Piotr H. (Lincoln Park, NJ), Waykole; Liladhar Murlidhar (Succasunna, NJ)
Assignee: Novartis AG (Basel, CH)
Application Number:13/993,217
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Novartis Pharms Corp
CAPSULE;ORAL205755-001Apr 29, 2014RXYesYes► Subscribe► SubscribeYY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 9,309,229

PCT Information
PCT FiledDecember 15, 2011PCT Application Number:PCT/US2011/065030
PCT Publication Date:June 21, 2012PCT Publication Number: WO2012/082972

International Patent Family for Patent: 9,309,229

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada2821102► Subscribe
Chile2013001723► Subscribe
China103282359► Subscribe
China104262324► Subscribe
China106008462► Subscribe
China106831716► Subscribe
China107056751► Subscribe
Colombia6801792► Subscribe
EcuadorSP13012770► Subscribe
European Patent Office2651918► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Farmers Insurance
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus